Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000010969 | SCV004363668 | pathogenic | Hereditary factor VIII deficiency disease | 2024-02-09 | reviewed by expert panel | curation | The NM_000132.3(F8):c.4121_4124del (p.Ile1374fs) variant is a frameshift variant that is predicted to introduce a premature stop codon in exon 14 and expected to result in nonsense-mediated mRNA decay, which meets PVS1. It is reported in at least 7 patients with moderate or severe hemophilia A in the literature reviewed (PMID: 22103590, 20102490, 8307558, 9829908, 17498081, 20028422) meeting PS4_Very strong. There are additional probands with the variant reported in the EAHAD database, recorded from the literature. The variant is absent from gnomAD v2.1.1 and v3, which meets PM2_Supporting. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F8: PVS1, PS4, PM2_Supporting. |
Fulgent Genetics, |
RCV002490352 | SCV002776346 | pathogenic | Hereditary factor VIII deficiency disease; Thrombophilia, X-linked, due to factor 8 defect | 2021-08-04 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000010969 | SCV000031196 | pathogenic | Hereditary factor VIII deficiency disease | 1993-12-01 | no assertion criteria provided | literature only | |
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, |
RCV000010969 | SCV001424864 | pathogenic | Hereditary factor VIII deficiency disease | 2019-06-01 | no assertion criteria provided | clinical testing |